Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Liabilities

Thread View: bionet.general

1 messages

[T] Back to Threads [V] Tree View [G] Group Articles

1 total messages Started by Sciclips Mon, 16 Jan 2012 06:33

#2196

Author: Sciclips
Date: Mon, 16 Jan 2012 06:33

14 lines
2413 bytes

This blog critically analyzes the potential scientific limitations,
risks and liabilities of cell based reporter assays, including non-
natural protein based reporter assays (e.g. circularly permuted
firefly luciferase or GFP based reporter assays) and stem cell based
assays, in drug discovery and development.  Scientific arguments have
been put forward to suggest that current format of cell based reporter
assays may not be ideal for replacing animal studies. This blog also
analyzes the potential negative impact of patents and intellectual
property (IP) rights in fostering innovations in cell based assays.
Finally, this blog warrants imposing accountability, tighter
regulations and demanding higher standards in cell based assays that
are used in drug discovery and development. Please follow this link to
read the full blog article:
http://sciclips.wordpress.com/2012/01/16/cell-based-reporter-assays-vs-animal-studies-in-drug-discovery-potential-limitations-risks-and-liabilities/

Thread Navigation

This is a paginated view of messages in the thread with full content displayed inline.

Messages are displayed in chronological order, with the original post highlighted in green.

Use pagination controls to navigate through all messages in large threads.

Back to All Threads